“The current condition has exposed some structural weaknesses while in the EU’s medicines source chain along with a large dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides mentioned. She advisable that provide chain troubles be addressed within an EU pharmaceutical appr